#United States #New York #Securities Fraud #Pomerantz LLP #Park Ha

Investor Alert: Class Action Lawsuit Filed Against Park Ha Biological Technology Co., Ltd.

The Pomerantz Law Firm recently announced the filing of a class action lawsuit against Park Ha Biological Technology Co., Ltd., a company listed on NASDAQ under the ticker BYAH. This lawsuit comes in response to allegations of securities fraud and misconduct by the company and its officers. Investors who have incurred losses in their investments with Park Ha are urged to take note of this legal initiative and consider joining the collective action to seek restitution.

What Are the Allegations?

According to the complaint, Park Ha has been implicated in a form of market manipulation that included a "pump-and-dump" scheme. This scheme reportedly relied on misleading information disseminated through social media channels. The lawsuit indicates that certain individuals posed as legitimate financial advisors, promoting Park Ha's stock within online communities and forums, which led to an artificial increase in the company’s share prices.

The allegations state that when Park Ha went public, its share price surged dramatically from an initial offering price of $4.00 to a peak of $41.49 by July 2025. Surprisingly, this increase occurred despite the lack of any significant corporate developments or genuine business progress. The lawsuit claims this spike was fueled by fraudulent promotional activities and that the company’s stock was manipulated through dubious online practices.

Key Deadlines for Investors

Investors who acquired Park Ha’s securities during the designated class period have until September 28, 2026, to apply for appointment as Lead Plaintiff for this class action lawsuit. Interested parties should reach out to the Pomerantz Law Firm, providing their contact information and investment details. Specifics regarding the filing and the nature of the lawsuit can be requested through Pomerantz’s official website.

The Role of Pomerantz LLP

Pomerantz LLP is a prestigious law firm with an established reputation in the field of securities and antitrust class actions. Since its inception more than 85 years ago by Abraham L. Pomerantz, the firm has championed the rights of victims of corporate fraud and misconduct. They have successfully recovered substantial damages for affected investors, demonstrating a commitment to holding corporations accountable for unethical practices.

As this case develops, Pomerantz is positioned to aid investors in navigating the complexities of securities law and ensure that they understand their rights amid legal proceedings. The firm is well-equipped with the resources and expertise to represent class members effectively and aims to rectify the alleged injustices faced by Park Ha's investors.

Conclusion

As investigations progress and the legal framework surrounding this class action solidifies, affected investors are encouraged to take proactive steps to protect their interests. The unfolding situation at Park Ha Biological Technology Co., Ltd. serves as a potent reminder of the vigilance required in the ever-evolving landscape of financial investments. Investors should remain informed, act promptly, and consider leveraging legal avenues to seek redress for their losses.

For further information on the lawsuit or to join as a plaintiff, investors can contact Danielle Peyton at Pomerantz LLP through the firm's website or by telephone.

By staying informed and utilizing legal resources, investors can better protect themselves against potential fraud in the financial markets.